CETYLEV Drug Patent Profile
✉ Email this page to a colleague
When do Cetylev patents expire, and when can generic versions of Cetylev launch?
Cetylev is a drug marketed by Arbor Pharms Llc and is included in one NDA. There are three patents protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in CETYLEV is acetylcysteine. There are three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cetylev
A generic version of CETYLEV was approved as acetylcysteine by HOSPIRA on August 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CETYLEV?
- What are the global sales for CETYLEV?
- What is Average Wholesale Price for CETYLEV?
Summary for CETYLEV
International Patents: | 1 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 158 |
Clinical Trials: | 1 |
Patent Applications: | 35 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CETYLEV |
DailyMed Link: | CETYLEV at DailyMed |
Recent Clinical Trials for CETYLEV
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Maryland, Baltimore | Phase 1/Phase 2 |
University of Maryland | Phase 1/Phase 2 |
US Patents and Regulatory Information for CETYLEV
CETYLEV is protected by three US patents.
Patents protecting CETYLEV
Effervescent compositions containing N-acetylcysteine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ACETAMINOPHEN OVERDOSE WITH ACETYLCYSTEINE SOLUTIONS
Effervescent compositions containing N-acetylcysteine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Effervescent compositions containing N-acetylcysteine
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD OF TREATING ACETAMINOPHEN OVERDOSE WITH ACETYLCYSTEINE SOLUTIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-002 | Jan 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-001 | Jan 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-002 | Jan 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-002 | Jan 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-001 | Jan 29, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CETYLEV
See the table below for patents covering CETYLEV around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2662077 | COMPOSITION EFFERVESCENTE CONTENANT DE LA N-ACÉTYL-CYSTÉINE (EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |